Patent · US Active

Interference control panel for evaluation of analytical assays for samples derived from blood

US8097461B2 · kind B2 · utility

1Cited by
0References
26Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 15, 2007
Grant dateJan 17, 2012
Priority date
Expiry dateDec 14, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/145555
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention relates to quality control of analytical assays, particularly NAT assays of blood samples containing nucleic acids. A control panel containing quantified amounts of substances known to interfere with an analytical assay is used and compared with a reference sample in the analytical assay. A comparison of the assay results interference panel validates the assay and can serve as a periodic quality control check for the analytical assay as well as related methods and protocols. The use of the control panel of the invention can also determine whether interfering substances are present and establish under what conditions the analytical assay reliable.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.